Breast cancer patients with dysfunctional TLR4 alleles experience faster recurrence after radiation and chemotherapy compared to those with normal TLR4 alleles (236, 239, 240), indicating a close association between TLR4 and anti-tumor immune responses. Here, TLR4 is linked to breast carcinoma.